Industry Research Reports

Home > Reports > Service & Software > Cancer Diagnostics Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Cancer Diagnostics Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-12-12

Pages: 132 Pages

Report ld: 5541604

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Cancer Diagnostics Service Market Size(US$)

CAGR 2025-2031

9.9%

Market Size,2031

USD 270,115

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 153,642 million

Market Forecast in 2031(Value)

US$ 270,115 million

CAGR

9.9%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Cancer Diagnostics Service was estimated to be worth US$ 39676 million in 2024 and is forecast to a readjusted size of US$ 270115 million by 2031 with a CAGR of 9.9% during the forecast period 2025-2031.

Cancer diagnostic services refer to medical technology services that utilize imaging examinations (such as CT, MRI, PET-CT) and in vitro diagnostics (including tumor marker detection, liquid biopsy, gene sequencing, pathological sections, and molecular subtyping) to provide early cancer screening, diagnosis, subtyping, staging, and medication guidance for suspected or high-risk individuals. This encompasses the entire process from sample collection and laboratory analysis to clinical interpretation. The upstream of the industry chain includes suppliers of high-throughput sequencers (Illumina, Thermo Fisher), antibody reagents, fluorescent probes, pathology equipment, AI-assisted diagnostic algorithms, and bioinformatics databases. The midstream consists of diagnostic service providers, who must possess CAP/CLIA or China National Institutes for Clinical Laboratories certification, NGS platforms, bioinformatics analysis capabilities, and compliant data management systems. The downstream primarily targets hospitals, health checkup centers, pharmaceutical companies (with companion diagnostics collaborations), and individual consumers. Due to its technology-intensive nature, high licensing barriers, and the inclusion of some services in medical insurance, the industry's overall gross profit margin is between 50% and 75%, with routine pathology and immunohistochemistry gross profit margins around 40%–60%, while NGS-based multi-cancer early screening or MRD monitoring services can achieve gross profit margins exceeding 70%.

The Cancer Diagnostics Service market is expanding rapidly due to the rising global cancer incidence, aging populations, and increasing demand for early detection. Advances in molecular diagnostics, next-generation sequencing, and liquid biopsy technologies are transforming traditional cancer testing into more precise and less invasive approaches. Governments are strengthening cancer screening programs, while precision medicine is driving higher demand for companion diagnostics. Additionally, AI-powered imaging analysis and digital pathology platforms are improving diagnostic efficiency and accuracy. In the future, integrated multi-omics diagnostics and personalized cancer screening solutions will further drive sustained growth of the global cancer diagnostics service market.

This report aims to provide a comprehensive presentation of the global market for Cancer Diagnostics Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cancer Diagnostics Service by region & country, by Type, and by Application.

The Cancer Diagnostics Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Diagnostics Service.

MARKET SEGMENTATION

By Company

Illumina
BGI Genomics Co.,Ltd.
Agilent Technologies
Macrogen
UCSF Health
Abbott
QIAGEN
Siemens Healthcare GmbH
Thermo Fisher Scientific, Inc.
Applied DNA Sciences
TherapySelect
Caris Life Sciences
Foresight Diagnostics
Smartpraxis
Amadix
Check4Cancer
Hologic
RGCC
ICON

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Breast Cancer
Blood Cancer
Lung Cancer
Colorectal Cancer
Ovarian Cancer
Others

Segment by Application

Hospitals
Ambulatory Surgical Centers
Diagnostic Laboratories
Others

Segment by Category

Imaging-based Cancer Diagnostics
Pathology-based Cancer Diagnostics
Molecular Cancer Diagnostics
Biomarker-based Cancer Diagnostics

Segment by Division

Genetic Testing
Liquid Biopsy
Tissue Biopsy
Immunohistochemistry (IHC)

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Cancer Diagnostics Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Cancer Diagnostics Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Cancer Diagnostics Service in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Cancer Diagnostics Service Product Introduction

1.2 Global Cancer Diagnostics Service Market Size Forecast (2020-2031)

1.3 Cancer Diagnostics Service Market Trends & Drivers

1.3.1 Cancer Diagnostics Service Industry Trends

1.3.2 Cancer Diagnostics Service Market Drivers & Opportunity

1.3.3 Cancer Diagnostics Service Market Challenges

1.3.4 Cancer Diagnostics Service Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Cancer Diagnostics Service Players Revenue Ranking (2024)

2.2 Global Cancer Diagnostics Service Revenue by Company (2020-2025)

2.3 Key Companies Cancer Diagnostics Service Manufacturing Base Distribution and Headquarters

2.4 Key Companies Cancer Diagnostics Service Product Offered

2.5 Key Companies Time to Begin Mass Production of Cancer Diagnostics Service

2.6 Cancer Diagnostics Service Market Competitive Analysis

2.6.1 Cancer Diagnostics Service Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Cancer Diagnostics Service Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Diagnostics Service as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Breast Cancer

3.1.2 Blood Cancer

3.1.3 Lung Cancer

3.1.4 Colorectal Cancer

3.1.5 Ovarian Cancer

3.1.6 Others

3.2 Global Cancer Diagnostics Service Sales Value by Type

3.2.1 Global Cancer Diagnostics Service Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Cancer Diagnostics Service Sales Value, by Type (2020-2031)

3.2.3 Global Cancer Diagnostics Service Sales Value, by Type (%) (2020-2031)

4 Segmentation by Diagnostic Technology

4.1 Introduction by Diagnostic Technology

4.1.1 Imaging-based Cancer Diagnostics

4.1.2 Pathology-based Cancer Diagnostics

4.1.3 Molecular Cancer Diagnostics

4.1.4 Biomarker-based Cancer Diagnostics

4.2 Global Cancer Diagnostics Service Sales Value by Diagnostic Technology

4.2.1 Global Cancer Diagnostics Service Sales Value by Diagnostic Technology (2020 VS 2024 VS 2031)

4.2.2 Global Cancer Diagnostics Service Sales Value, by Diagnostic Technology (2020-2031)

4.2.3 Global Cancer Diagnostics Service Sales Value, by Diagnostic Technology (%) (2020-2031)

5 Segmentation by Testing Method

5.1 Introduction by Testing Method

5.1.1 Genetic Testing

5.1.2 Liquid Biopsy

5.1.3 Tissue Biopsy

5.1.4 Immunohistochemistry (IHC)

5.2 Global Cancer Diagnostics Service Sales Value by Testing Method

5.2.1 Global Cancer Diagnostics Service Sales Value by Testing Method (2020 VS 2024 VS 2031)

5.2.2 Global Cancer Diagnostics Service Sales Value, by Testing Method (2020-2031)

5.2.3 Global Cancer Diagnostics Service Sales Value, by Testing Method (%) (2020-2031)

6 Segmentation by Application

6.1 Introduction by Application

6.1.1 Hospitals

6.1.2 Ambulatory Surgical Centers

6.1.3 Diagnostic Laboratories

6.1.4 Others

6.2 Global Cancer Diagnostics Service Sales Value by Application

6.2.1 Global Cancer Diagnostics Service Sales Value by Application (2020 VS 2024 VS 2031)

6.2.2 Global Cancer Diagnostics Service Sales Value, by Application (2020-2031)

6.2.3 Global Cancer Diagnostics Service Sales Value, by Application (%) (2020-2031)

7 Segmentation by Region

7.1 Global Cancer Diagnostics Service Sales Value by Region

7.1.1 Global Cancer Diagnostics Service Sales Value by Region: 2020 VS 2024 VS 2031

7.1.2 Global Cancer Diagnostics Service Sales Value by Region (2020-2025)

7.1.3 Global Cancer Diagnostics Service Sales Value by Region (2026-2031)

7.1.4 Global Cancer Diagnostics Service Sales Value by Region (%), (2020-2031)

7.2 North America

7.2.1 North America Cancer Diagnostics Service Sales Value, 2020-2031

7.2.2 North America Cancer Diagnostics Service Sales Value by Country (%), 2024 VS 2031

7.3 Europe

7.3.1 Europe Cancer Diagnostics Service Sales Value, 2020-2031

7.3.2 Europe Cancer Diagnostics Service Sales Value by Country (%), 2024 VS 2031

7.4 Asia Pacific

7.4.1 Asia Pacific Cancer Diagnostics Service Sales Value, 2020-2031

7.4.2 Asia Pacific Cancer Diagnostics Service Sales Value by Region (%), 2024 VS 2031

7.5 South America

7.5.1 South America Cancer Diagnostics Service Sales Value, 2020-2031

7.5.2 South America Cancer Diagnostics Service Sales Value by Country (%), 2024 VS 2031

7.6 Middle East & Africa

7.6.1 Middle East & Africa Cancer Diagnostics Service Sales Value, 2020-2031

7.6.2 Middle East & Africa Cancer Diagnostics Service Sales Value by Country (%), 2024 VS 2031

8 Segmentation by Key Countries/Regions

8.1 Key Countries/Regions Cancer Diagnostics Service Sales Value Growth Trends, 2020 VS 2024 VS 2031

8.2 Key Countries/Regions Cancer Diagnostics Service Sales Value, 2020-2031

8.3 United States

8.3.1 United States Cancer Diagnostics Service Sales Value, 2020-2031

8.3.2 United States Cancer Diagnostics Service Sales Value by Type (%), 2024 VS 2031

8.3.3 United States Cancer Diagnostics Service Sales Value by Application, 2024 VS 2031

8.4 Europe

8.4.1 Europe Cancer Diagnostics Service Sales Value, 2020-2031

8.4.2 Europe Cancer Diagnostics Service Sales Value by Type (%), 2024 VS 2031

8.4.3 Europe Cancer Diagnostics Service Sales Value by Application, 2024 VS 2031

8.5 China

8.5.1 China Cancer Diagnostics Service Sales Value, 2020-2031

8.5.2 China Cancer Diagnostics Service Sales Value by Type (%), 2024 VS 2031

8.5.3 China Cancer Diagnostics Service Sales Value by Application, 2024 VS 2031

8.6 Japan

8.6.1 Japan Cancer Diagnostics Service Sales Value, 2020-2031

8.6.2 Japan Cancer Diagnostics Service Sales Value by Type (%), 2024 VS 2031

8.6.3 Japan Cancer Diagnostics Service Sales Value by Application, 2024 VS 2031

8.7 South Korea

8.7.1 South Korea Cancer Diagnostics Service Sales Value, 2020-2031

8.7.2 South Korea Cancer Diagnostics Service Sales Value by Type (%), 2024 VS 2031

8.7.3 South Korea Cancer Diagnostics Service Sales Value by Application, 2024 VS 2031

8.8 Southeast Asia

8.8.1 Southeast Asia Cancer Diagnostics Service Sales Value, 2020-2031

8.8.2 Southeast Asia Cancer Diagnostics Service Sales Value by Type (%), 2024 VS 2031

8.8.3 Southeast Asia Cancer Diagnostics Service Sales Value by Application, 2024 VS 2031

8.9 India

8.9.1 India Cancer Diagnostics Service Sales Value, 2020-2031

8.9.2 India Cancer Diagnostics Service Sales Value by Type (%), 2024 VS 2031

8.9.3 India Cancer Diagnostics Service Sales Value by Application, 2024 VS 2031

9 Company Profiles

9.1 Illumina

9.1.1 Illumina Profile

9.1.2 Illumina Main Business

9.1.3 Illumina Cancer Diagnostics Service Products, Services and Solutions

9.1.4 Illumina Cancer Diagnostics Service Revenue (US$ Million) & (2020-2025)

9.1.5 Illumina Recent Developments

9.2 BGI Genomics Co.,Ltd.

9.2.1 BGI Genomics Co.,Ltd. Profile

9.2.2 BGI Genomics Co.,Ltd. Main Business

9.2.3 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Products, Services and Solutions

9.2.4 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Revenue (US$ Million) & (2020-2025)

9.2.5 BGI Genomics Co.,Ltd. Recent Developments

9.3 Agilent Technologies

9.3.1 Agilent Technologies Profile

9.3.2 Agilent Technologies Main Business

9.3.3 Agilent Technologies Cancer Diagnostics Service Products, Services and Solutions

9.3.4 Agilent Technologies Cancer Diagnostics Service Revenue (US$ Million) & (2020-2025)

9.3.5 Agilent Technologies Recent Developments

9.4 Macrogen

9.4.1 Macrogen Profile

9.4.2 Macrogen Main Business

9.4.3 Macrogen Cancer Diagnostics Service Products, Services and Solutions

9.4.4 Macrogen Cancer Diagnostics Service Revenue (US$ Million) & (2020-2025)

9.4.5 Macrogen Recent Developments

9.5 UCSF Health

9.5.1 UCSF Health Profile

9.5.2 UCSF Health Main Business

9.5.3 UCSF Health Cancer Diagnostics Service Products, Services and Solutions

9.5.4 UCSF Health Cancer Diagnostics Service Revenue (US$ Million) & (2020-2025)

9.5.5 UCSF Health Recent Developments

9.6 Abbott

9.6.1 Abbott Profile

9.6.2 Abbott Main Business

9.6.3 Abbott Cancer Diagnostics Service Products, Services and Solutions

9.6.4 Abbott Cancer Diagnostics Service Revenue (US$ Million) & (2020-2025)

9.6.5 Abbott Recent Developments

9.7 QIAGEN

9.7.1 QIAGEN Profile

9.7.2 QIAGEN Main Business

9.7.3 QIAGEN Cancer Diagnostics Service Products, Services and Solutions

9.7.4 QIAGEN Cancer Diagnostics Service Revenue (US$ Million) & (2020-2025)

9.7.5 QIAGEN Recent Developments

9.8 Siemens Healthcare GmbH

9.8.1 Siemens Healthcare GmbH Profile

9.8.2 Siemens Healthcare GmbH Main Business

9.8.3 Siemens Healthcare GmbH Cancer Diagnostics Service Products, Services and Solutions

9.8.4 Siemens Healthcare GmbH Cancer Diagnostics Service Revenue (US$ Million) & (2020-2025)

9.8.5 Siemens Healthcare GmbH Recent Developments

9.9 Thermo Fisher Scientific, Inc.

9.9.1 Thermo Fisher Scientific, Inc. Profile

9.9.2 Thermo Fisher Scientific, Inc. Main Business

9.9.3 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Products, Services and Solutions

9.9.4 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Revenue (US$ Million) & (2020-2025)

9.9.5 Thermo Fisher Scientific, Inc. Recent Developments

9.10 Applied DNA Sciences

9.10.1 Applied DNA Sciences Profile

9.10.2 Applied DNA Sciences Main Business

9.10.3 Applied DNA Sciences Cancer Diagnostics Service Products, Services and Solutions

9.10.4 Applied DNA Sciences Cancer Diagnostics Service Revenue (US$ Million) & (2020-2025)

9.10.5 Applied DNA Sciences Recent Developments

9.11 TherapySelect

9.11.1 TherapySelect Profile

9.11.2 TherapySelect Main Business

9.11.3 TherapySelect Cancer Diagnostics Service Products, Services and Solutions

9.11.4 TherapySelect Cancer Diagnostics Service Revenue (US$ Million) & (2020-2025)

9.11.5 TherapySelect Recent Developments

9.12 Caris Life Sciences

9.12.1 Caris Life Sciences Profile

9.12.2 Caris Life Sciences Main Business

9.12.3 Caris Life Sciences Cancer Diagnostics Service Products, Services and Solutions

9.12.4 Caris Life Sciences Cancer Diagnostics Service Revenue (US$ Million) & (2020-2025)

9.12.5 Caris Life Sciences Recent Developments

9.13 Foresight Diagnostics

9.13.1 Foresight Diagnostics Profile

9.13.2 Foresight Diagnostics Main Business

9.13.3 Foresight Diagnostics Cancer Diagnostics Service Products, Services and Solutions

9.13.4 Foresight Diagnostics Cancer Diagnostics Service Revenue (US$ Million) & (2020-2025)

9.13.5 Foresight Diagnostics Recent Developments

9.14 Smartpraxis

9.14.1 Smartpraxis Profile

9.14.2 Smartpraxis Main Business

9.14.3 Smartpraxis Cancer Diagnostics Service Products, Services and Solutions

9.14.4 Smartpraxis Cancer Diagnostics Service Revenue (US$ Million) & (2020-2025)

9.14.5 Smartpraxis Recent Developments

9.15 Amadix

9.15.1 Amadix Profile

9.15.2 Amadix Main Business

9.15.3 Amadix Cancer Diagnostics Service Products, Services and Solutions

9.15.4 Amadix Cancer Diagnostics Service Revenue (US$ Million) & (2020-2025)

9.15.5 Amadix Recent Developments

9.16 Check4Cancer

9.16.1 Check4Cancer Profile

9.16.2 Check4Cancer Main Business

9.16.3 Check4Cancer Cancer Diagnostics Service Products, Services and Solutions

9.16.4 Check4Cancer Cancer Diagnostics Service Revenue (US$ Million) & (2020-2025)

9.16.5 Check4Cancer Recent Developments

9.17 Hologic

9.17.1 Hologic Profile

9.17.2 Hologic Main Business

9.17.3 Hologic Cancer Diagnostics Service Products, Services and Solutions

9.17.4 Hologic Cancer Diagnostics Service Revenue (US$ Million) & (2020-2025)

9.17.5 Hologic Recent Developments

9.18 RGCC

9.18.1 RGCC Profile

9.18.2 RGCC Main Business

9.18.3 RGCC Cancer Diagnostics Service Products, Services and Solutions

9.18.4 RGCC Cancer Diagnostics Service Revenue (US$ Million) & (2020-2025)

9.18.5 RGCC Recent Developments

9.19 ICON

9.19.1 ICON Profile

9.19.2 ICON Main Business

9.19.3 ICON Cancer Diagnostics Service Products, Services and Solutions

9.19.4 ICON Cancer Diagnostics Service Revenue (US$ Million) & (2020-2025)

9.19.5 ICON Recent Developments

10 Industry Chain Analysis

10.1 Cancer Diagnostics Service Industrial Chain

10.2 Cancer Diagnostics Service Upstream Analysis

10.2.1 Key Raw Materials

10.2.2 Raw Materials Key Suppliers

10.2.3 Manufacturing Cost Structure

10.3 Midstream Analysis

10.4 Downstream Analysis (Customers Analysis)

10.5 Sales Model and Sales Channels

10.5.1 Cancer Diagnostics Service Sales Model

10.5.2 Sales Channel

10.5.3 Cancer Diagnostics Service Distributors

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Cancer Diagnostics Service Market Trends

Table 2. Cancer Diagnostics Service Market Drivers & Opportunity

Table 3. Cancer Diagnostics Service Market Challenges

Table 4. Cancer Diagnostics Service Market Restraints

Table 5. Global Cancer Diagnostics Service Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Cancer Diagnostics Service Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Cancer Diagnostics Service Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Cancer Diagnostics Service Product Type

Table 9. Key Companies Time to Begin Mass Production of Cancer Diagnostics Service

Table 10. Global Cancer Diagnostics Service Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Diagnostics Service as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Cancer Diagnostics Service Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Cancer Diagnostics Service Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global Cancer Diagnostics Service Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global Cancer Diagnostics Service Sales Market Share in Value by Type (2020-2025)

Table 17. Global Cancer Diagnostics Service Sales Market Share in Value by Type (2026-2031)

Table 18. Global Cancer Diagnostics Service Sales Value by Diagnostic Technology: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Cancer Diagnostics Service Sales Value by Diagnostic Technology (2020-2025) & (US$ Million)

Table 20. Global Cancer Diagnostics Service Sales Value by Diagnostic Technology (2026-2031) & (US$ Million)

Table 21. Global Cancer Diagnostics Service Sales Market Share in Value by Diagnostic Technology (2020-2025)

Table 22. Global Cancer Diagnostics Service Sales Market Share in Value by Diagnostic Technology (2026-2031)

Table 23. Global Cancer Diagnostics Service Sales Value by Testing Method: 2020 VS 2024 VS 2031 (US$ Million)

Table 24. Global Cancer Diagnostics Service Sales Value by Testing Method (2020-2025) & (US$ Million)

Table 25. Global Cancer Diagnostics Service Sales Value by Testing Method (2026-2031) & (US$ Million)

Table 26. Global Cancer Diagnostics Service Sales Market Share in Value by Testing Method (2020-2025)

Table 27. Global Cancer Diagnostics Service Sales Market Share in Value by Testing Method (2026-2031)

Table 28. Global Cancer Diagnostics Service Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Cancer Diagnostics Service Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Cancer Diagnostics Service Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Cancer Diagnostics Service Sales Market Share in Value by Application (2020-2025)

Table 32. Global Cancer Diagnostics Service Sales Market Share in Value by Application (2026-2031)

Table 33. Global Cancer Diagnostics Service Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 34. Global Cancer Diagnostics Service Sales Value by Region (2020-2025) & (US$ Million)

Table 35. Global Cancer Diagnostics Service Sales Value by Region (2026-2031) & (US$ Million)

Table 36. Global Cancer Diagnostics Service Sales Value by Region (2020-2025) & (%)

Table 37. Global Cancer Diagnostics Service Sales Value by Region (2026-2031) & (%)

Table 38. Key Countries/Regions Cancer Diagnostics Service Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 39. Key Countries/Regions Cancer Diagnostics Service Sales Value, (2020-2025) & (US$ Million)

Table 40. Key Countries/Regions Cancer Diagnostics Service Sales Value, (2026-2031) & (US$ Million)

Table 41. Illumina Basic Information List

Table 42. Illumina Description and Business Overview

Table 43. Illumina Cancer Diagnostics Service Products, Services and Solutions

Table 44. Revenue (US$ Million) in Cancer Diagnostics Service Business of Illumina (2020-2025)

Table 45. Illumina Recent Developments

Table 46. BGI Genomics Co.,Ltd. Basic Information List

Table 47. BGI Genomics Co.,Ltd. Description and Business Overview

Table 48. BGI Genomics Co.,Ltd. Cancer Diagnostics Service Products, Services and Solutions

Table 49. Revenue (US$ Million) in Cancer Diagnostics Service Business of BGI Genomics Co.,Ltd. (2020-2025)

Table 50. BGI Genomics Co.,Ltd. Recent Developments

Table 51. Agilent Technologies Basic Information List

Table 52. Agilent Technologies Description and Business Overview

Table 53. Agilent Technologies Cancer Diagnostics Service Products, Services and Solutions

Table 54. Revenue (US$ Million) in Cancer Diagnostics Service Business of Agilent Technologies (2020-2025)

Table 55. Agilent Technologies Recent Developments

Table 56. Macrogen Basic Information List

Table 57. Macrogen Description and Business Overview

Table 58. Macrogen Cancer Diagnostics Service Products, Services and Solutions

Table 59. Revenue (US$ Million) in Cancer Diagnostics Service Business of Macrogen (2020-2025)

Table 60. Macrogen Recent Developments

Table 61. UCSF Health Basic Information List

Table 62. UCSF Health Description and Business Overview

Table 63. UCSF Health Cancer Diagnostics Service Products, Services and Solutions

Table 64. Revenue (US$ Million) in Cancer Diagnostics Service Business of UCSF Health (2020-2025)

Table 65. UCSF Health Recent Developments

Table 66. Abbott Basic Information List

Table 67. Abbott Description and Business Overview

Table 68. Abbott Cancer Diagnostics Service Products, Services and Solutions

Table 69. Revenue (US$ Million) in Cancer Diagnostics Service Business of Abbott (2020-2025)

Table 70. Abbott Recent Developments

Table 71. QIAGEN Basic Information List

Table 72. QIAGEN Description and Business Overview

Table 73. QIAGEN Cancer Diagnostics Service Products, Services and Solutions

Table 74. Revenue (US$ Million) in Cancer Diagnostics Service Business of QIAGEN (2020-2025)

Table 75. QIAGEN Recent Developments

Table 76. Siemens Healthcare GmbH Basic Information List

Table 77. Siemens Healthcare GmbH Description and Business Overview

Table 78. Siemens Healthcare GmbH Cancer Diagnostics Service Products, Services and Solutions

Table 79. Revenue (US$ Million) in Cancer Diagnostics Service Business of Siemens Healthcare GmbH (2020-2025)

Table 80. Siemens Healthcare GmbH Recent Developments

Table 81. Thermo Fisher Scientific, Inc. Basic Information List

Table 82. Thermo Fisher Scientific, Inc. Description and Business Overview

Table 83. Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Products, Services and Solutions

Table 84. Revenue (US$ Million) in Cancer Diagnostics Service Business of Thermo Fisher Scientific, Inc. (2020-2025)

Table 85. Thermo Fisher Scientific, Inc. Recent Developments

Table 86. Applied DNA Sciences Basic Information List

Table 87. Applied DNA Sciences Description and Business Overview

Table 88. Applied DNA Sciences Cancer Diagnostics Service Products, Services and Solutions

Table 89. Revenue (US$ Million) in Cancer Diagnostics Service Business of Applied DNA Sciences (2020-2025)

Table 90. Applied DNA Sciences Recent Developments

Table 91. TherapySelect Basic Information List

Table 92. TherapySelect Description and Business Overview

Table 93. TherapySelect Cancer Diagnostics Service Products, Services and Solutions

Table 94. Revenue (US$ Million) in Cancer Diagnostics Service Business of TherapySelect (2020-2025)

Table 95. TherapySelect Recent Developments

Table 96. Caris Life Sciences Basic Information List

Table 97. Caris Life Sciences Description and Business Overview

Table 98. Caris Life Sciences Cancer Diagnostics Service Products, Services and Solutions

Table 99. Revenue (US$ Million) in Cancer Diagnostics Service Business of Caris Life Sciences (2020-2025)

Table 100. Caris Life Sciences Recent Developments

Table 101. Foresight Diagnostics Basic Information List

Table 102. Foresight Diagnostics Description and Business Overview

Table 103. Foresight Diagnostics Cancer Diagnostics Service Products, Services and Solutions

Table 104. Revenue (US$ Million) in Cancer Diagnostics Service Business of Foresight Diagnostics (2020-2025)

Table 105. Foresight Diagnostics Recent Developments

Table 106. Smartpraxis Basic Information List

Table 107. Smartpraxis Description and Business Overview

Table 108. Smartpraxis Cancer Diagnostics Service Products, Services and Solutions

Table 109. Revenue (US$ Million) in Cancer Diagnostics Service Business of Smartpraxis (2020-2025)

Table 110. Smartpraxis Recent Developments

Table 111. Amadix Basic Information List

Table 112. Amadix Description and Business Overview

Table 113. Amadix Cancer Diagnostics Service Products, Services and Solutions

Table 114. Revenue (US$ Million) in Cancer Diagnostics Service Business of Amadix (2020-2025)

Table 115. Amadix Recent Developments

Table 116. Check4Cancer Basic Information List

Table 117. Check4Cancer Description and Business Overview

Table 118. Check4Cancer Cancer Diagnostics Service Products, Services and Solutions

Table 119. Revenue (US$ Million) in Cancer Diagnostics Service Business of Check4Cancer (2020-2025)

Table 120. Check4Cancer Recent Developments

Table 121. Hologic Basic Information List

Table 122. Hologic Description and Business Overview

Table 123. Hologic Cancer Diagnostics Service Products, Services and Solutions

Table 124. Revenue (US$ Million) in Cancer Diagnostics Service Business of Hologic (2020-2025)

Table 125. Hologic Recent Developments

Table 126. RGCC Basic Information List

Table 127. RGCC Description and Business Overview

Table 128. RGCC Cancer Diagnostics Service Products, Services and Solutions

Table 129. Revenue (US$ Million) in Cancer Diagnostics Service Business of RGCC (2020-2025)

Table 130. RGCC Recent Developments

Table 131. ICON Basic Information List

Table 132. ICON Description and Business Overview

Table 133. ICON Cancer Diagnostics Service Products, Services and Solutions

Table 134. Revenue (US$ Million) in Cancer Diagnostics Service Business of ICON (2020-2025)

Table 135. ICON Recent Developments

Table 136. Key Raw Materials Lists

Table 137. Raw Materials Key Suppliers Lists

Table 138. Cancer Diagnostics Service Downstream Customers

Table 139. Cancer Diagnostics Service Distributors List

Table 140. Research Programs/Design for This Report

Table 141. Key Data Information from Secondary Sources

Table 142. Key Data Information from Primary Sources

List of Figures

Figure 1. Cancer Diagnostics Service Product Picture

Figure 2. Global Cancer Diagnostics Service Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Cancer Diagnostics Service Sales Value (2020-2031) & (US$ Million)

Figure 4. Cancer Diagnostics Service Report Years Considered

Figure 5. Global Cancer Diagnostics Service Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Cancer Diagnostics Service Revenue in 2024

Figure 7. Cancer Diagnostics Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Breast Cancer Picture

Figure 9. Blood Cancer Picture

Figure 10. Lung Cancer Picture

Figure 11. Colorectal Cancer Picture

Figure 12. Ovarian Cancer Picture

Figure 13. Others Picture

Figure 14. Global Cancer Diagnostics Service Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 15. Global Cancer Diagnostics Service Sales Value Market Share by Type, 2024 & 2031

Figure 16. Imaging-based Cancer Diagnostics Picture

Figure 17. Pathology-based Cancer Diagnostics Picture

Figure 18. Molecular Cancer Diagnostics Picture

Figure 19. Biomarker-based Cancer Diagnostics Picture

Figure 20. Global Cancer Diagnostics Service Sales Value by Diagnostic Technology (2020 VS 2024 VS 2031) & (US$ Million)

Figure 21. Global Cancer Diagnostics Service Sales Value Market Share by Diagnostic Technology, 2024 & 2031

Figure 22. Genetic Testing Picture

Figure 23. Liquid Biopsy Picture

Figure 24. Tissue Biopsy Picture

Figure 25. Immunohistochemistry (IHC) Picture

Figure 26. Global Cancer Diagnostics Service Sales Value by Testing Method (2020 VS 2024 VS 2031) & (US$ Million)

Figure 27. Global Cancer Diagnostics Service Sales Value Market Share by Testing Method, 2024 & 2031

Figure 28. Product Picture of Hospitals

Figure 29. Product Picture of Ambulatory Surgical Centers

Figure 30. Product Picture of Diagnostic Laboratories

Figure 31. Product Picture of Others

Figure 32. Global Cancer Diagnostics Service Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 33. Global Cancer Diagnostics Service Sales Value Market Share by Application, 2024 & 2031

Figure 34. North America Cancer Diagnostics Service Sales Value (2020-2031) & (US$ Million)

Figure 35. North America Cancer Diagnostics Service Sales Value by Country (%), 2024 VS 2031

Figure 36. Europe Cancer Diagnostics Service Sales Value, (2020-2031) & (US$ Million)

Figure 37. Europe Cancer Diagnostics Service Sales Value by Country (%), 2024 VS 2031

Figure 38. Asia Pacific Cancer Diagnostics Service Sales Value, (2020-2031) & (US$ Million)

Figure 39. Asia Pacific Cancer Diagnostics Service Sales Value by Region (%), 2024 VS 2031

Figure 40. South America Cancer Diagnostics Service Sales Value, (2020-2031) & (US$ Million)

Figure 41. South America Cancer Diagnostics Service Sales Value by Country (%), 2024 VS 2031

Figure 42. Middle East & Africa Cancer Diagnostics Service Sales Value, (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Cancer Diagnostics Service Sales Value by Country (%), 2024 VS 2031

Figure 44. Key Countries/Regions Cancer Diagnostics Service Sales Value (%), (2020-2031)

Figure 45. United States Cancer Diagnostics Service Sales Value, (2020-2031) & (US$ Million)

Figure 46. United States Cancer Diagnostics Service Sales Value by Type (%), 2024 VS 2031

Figure 47. United States Cancer Diagnostics Service Sales Value by Application (%), 2024 VS 2031

Figure 48. Europe Cancer Diagnostics Service Sales Value, (2020-2031) & (US$ Million)

Figure 49. Europe Cancer Diagnostics Service Sales Value by Type (%), 2024 VS 2031

Figure 50. Europe Cancer Diagnostics Service Sales Value by Application (%), 2024 VS 2031

Figure 51. China Cancer Diagnostics Service Sales Value, (2020-2031) & (US$ Million)

Figure 52. China Cancer Diagnostics Service Sales Value by Type (%), 2024 VS 2031

Figure 53. China Cancer Diagnostics Service Sales Value by Application (%), 2024 VS 2031

Figure 54. Japan Cancer Diagnostics Service Sales Value, (2020-2031) & (US$ Million)

Figure 55. Japan Cancer Diagnostics Service Sales Value by Type (%), 2024 VS 2031

Figure 56. Japan Cancer Diagnostics Service Sales Value by Application (%), 2024 VS 2031

Figure 57. South Korea Cancer Diagnostics Service Sales Value, (2020-2031) & (US$ Million)

Figure 58. South Korea Cancer Diagnostics Service Sales Value by Type (%), 2024 VS 2031

Figure 59. South Korea Cancer Diagnostics Service Sales Value by Application (%), 2024 VS 2031

Figure 60. Southeast Asia Cancer Diagnostics Service Sales Value, (2020-2031) & (US$ Million)

Figure 61. Southeast Asia Cancer Diagnostics Service Sales Value by Type (%), 2024 VS 2031

Figure 62. Southeast Asia Cancer Diagnostics Service Sales Value by Application (%), 2024 VS 2031

Figure 63. India Cancer Diagnostics Service Sales Value, (2020-2031) & (US$ Million)

Figure 64. India Cancer Diagnostics Service Sales Value by Type (%), 2024 VS 2031

Figure 65. India Cancer Diagnostics Service Sales Value by Application (%), 2024 VS 2031

Figure 66. Cancer Diagnostics Service Industrial Chain

Figure 67. Cancer Diagnostics Service Manufacturing Cost Structure

Figure 68. Channels of Distribution (Direct Sales, and Distribution)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Cancer Diagnostics Service in 2025? zhanKai

The global market size of Cancer Diagnostics Service in 2025 was 153642 Million USD.

What was the global market size of Cancer Diagnostics Service in 2031? shouQi

Which companies rank high in the global Cancer Diagnostics Service market? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Cancer Diagnostics Service market size from 2025 to 2031? shouQi

Related Reports

Global Cancer Diagnostics Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cancer Diagnostics Service market size was US$ 153640 million in 2025 and is forecast to reach a readjusted size of US$ 294080 million by 2032 with a CAGR of 9.9% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 105
USD 4250.00
(Single User License)
Cancer Diagnostics Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cancer Diagnostics Service was estimated to be worth US$ 153640 million in 2025 and is projected to reach US$ 294080 million, growing at a CAGR of 9.9% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 128
USD 3950.00
(Single User License)
Global Cancer Diagnostics Service Market Research Report 2026
The global Cancer Diagnostics Service market was valued at US$ 153640 million in 2025 and is anticipated to reach US$ 294080 million by 2032, at a CAGR of 9.9% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 127
USD 2900.00
(Single User License)
Global Cancer Diagnostics Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cancer Diagnostics Service market size was US$ 39676 million in 2024 and is forecast to a readjusted size of US$ 270115 million by 2031 with a CAGR of 9.9% during the forecast period 2025-2031.
Published Date: 2025-12-12
Pages: 110
USD 4250.00
(Single User License)
Global Cancer Diagnostics Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cancer Diagnostics Service market is projected to grow from US$ 39676 million in 2024 to US$ 270115 million by 2031, at a CAGR of 9.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-12-12
Pages: 159
USD 4900.00
(Single User License)
Global Cancer Diagnostics Service Market Research Report 2025
The global market for Cancer Diagnostics Service was valued at US$ 39676 million in the year 2024 and is projected to reach a revised size of US$ 270115 million by 2031, growing at a CAGR of 9.9% during the forecast period.
Published Date: 2025-12-12
Pages: 139
USD 2900.00
(Single User License)
Cancer Diagnostics Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cancer Diagnostics Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-04
Pages: 96
USD 3950.00
(Single User License)
Global Cancer Diagnostics Service Market Insights, Forecast to 2030
Market Analysis and Insights: Global Cancer Diagnostics Service Market
Published Date: 2024-04-09
Pages: 105
USD 4900.00
(Single User License)
Global Cancer Diagnostics Service Market Research Report 2024
The global Cancer Diagnostics Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-08
Pages: 83
USD 2900.00
(Single User License)

Global Cancer Diagnostics Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cancer Diagnostics Service market size was US$ 153640 million in 2025 and is forecast to reach a readjusted size of US$ 294080 million by 2032 with a CAGR of 9.9% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 105
USD 4250.00 (Single User License)
Cancer Diagnostics Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cancer Diagnostics Service was estimated to be worth US$ 153640 million in 2025 and is projected to reach US$ 294080 million, growing at a CAGR of 9.9% from 2026 to 2032.
Published: 2026-03-06
Pages: 128
USD 3950.00 (Single User License)
Global Cancer Diagnostics Service Market Research Report 2026
The global Cancer Diagnostics Service market was valued at US$ 153640 million in 2025 and is anticipated to reach US$ 294080 million by 2032, at a CAGR of 9.9% from 2026 to 2032.
Published: 2026-03-06
Pages: 127
USD 2900.00 (Single User License)
Global Cancer Diagnostics Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cancer Diagnostics Service market size was US$ 39676 million in 2024 and is forecast to a readjusted size of US$ 270115 million by 2031 with a CAGR of 9.9% during the forecast period 2025-2031.
Published: 2025-12-12
Pages: 110
USD 4250.00 (Single User License)
Global Cancer Diagnostics Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cancer Diagnostics Service market is projected to grow from US$ 39676 million in 2024 to US$ 270115 million by 2031, at a CAGR of 9.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-12-12
Pages: 159
USD 4900.00 (Single User License)
Global Cancer Diagnostics Service Market Research Report 2025
The global market for Cancer Diagnostics Service was valued at US$ 39676 million in the year 2024 and is projected to reach a revised size of US$ 270115 million by 2031, growing at a CAGR of 9.9% during the forecast period.
Published: 2025-12-12
Pages: 139
USD 2900.00 (Single User License)
Cancer Diagnostics Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cancer Diagnostics Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-04
Pages: 96
USD 3950.00 (Single User License)
Global Cancer Diagnostics Service Market Insights, Forecast to 2030
Market Analysis and Insights: Global Cancer Diagnostics Service Market
Published: 2024-04-09
Pages: 105
USD 4900.00 (Single User License)
Global Cancer Diagnostics Service Market Research Report 2024
The global Cancer Diagnostics Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-08
Pages: 83
USD 2900.00 (Single User License)